News

FDA considers changing HRT warning, among 'greatest mistakes' in medicine: Commissioner | Elizabeth Vargas Reports
The FDA is reevaluating longtime warnings on hormone replacement therapy products for menopausal women. Some advocates for change say the so-called “black box” that lists health risks is discouraging ...
US may revise hormone replacement therapy warnings
US Food and Drug Administration Commissioner Marty Makary signaled Thursday that he is open to revising strict warning labels ...
F.D.A. Panelists Call for Removal of Warnings on Menopause Treatments
Dr. Marty Makary, the agency’s commissioner, has said too many women avoid menopause treatments because the risks have been ...
MedPage Today5h
A 'Culture Change' Is Needed in Academic Medicine, FDA Commissioner Says
The culture of academic medicine needs to change, FDA Commissioner Marty Makary, MD, MPH, said at an event sponsored by The ...
US health experts reassess hormone replacement therapy risks
US health authorities on Thursday began a reassessment of the risks surrounding Hormone Replacement Therapy (HRT), a ...
American Council on Science and Health13h
From Lab Rats to Chips: FDA Moves Beyond Animals
Real change takes a long time, and when it happens, it must be recognized. The FDA and the NIH have announced their move away ...